Schwind showcases new excimer laser

Article

Three years of research and development paid off today when Schwind eye-tech-solutions unveiled the Schwind AMARIS excimer laser to the refractive surgery community. According to CEO Rolf Schwind, it successfully combines all available state-of-the-art technologies in one single system.

Three years of research and development paid off today when Schwind eye-tech-solutions unveiled the Schwind AMARIS excimer laser to the refractive surgery community. According to CEO Rolf Schwind, it successfully combines all available state-of-the-art technologies in one single system.

Boasting a 1,050 Hz turbo eye tracker (5 D eye tracker), with a response time of less than three milliseconds, and other features, such as rotation balance, limbus tracking and static as well as dynamic cylcotorsion control, the company believes that it has produced the fastest and most accurate eye tracking system on the market.

Accuracy of ablation is governed by the system's "TotalTech Laser", which has a true pulse frequency of 500 Hz and two automatically adapted fluence values. Depending on the refraction to be corrected, approximately 80% of the corneal ablation is performed with a high fluence (high-speed) level, whilst fine correction takes place with a low fluence level. According to Schwind, one diopter of correction takes on average less than 2.5 seconds with the Schwind AMARIS, whilst the small beam diameter of 0.54 mm (FWHM) allows maximum precision and smooth treatment surfaces.

The laser's Intelligent Thermal Effect Control has been designed to provide dynamically adapted distribution of the laser pulses, thus reducing significant heating of the cornea and offering maximum protection to the stroma.

Other valuable features highlighted by the firm include: the continuous measurement of corneal thickness (using online pachymetry) during the procedure; the particle aspiration system, which removes energy-reducing particles; the Treatment Assistant Manager (TAM), which guides the surgeon through each treatment step; and the unique ergonomics, which optimise the treatment process and contribute to patient comfort.

"With the Schwind AMARIS, we have developed an all-rounder with unmatched high performance, thereby offering an extraordinarily high level of accuracy and safety and the first and only laser to combine all state-of-the-art technologies in one system," enthused Rolf Schwind.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.